Plain-English translation of NCT06704581 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called BGM0504 to see if it can help adults who are overweight or obese lose weight and keep it off. The medication would be given as a weekly injection, and you'd also be expected to follow diet and exercise guidance. Researchers want to understand how well this treatment works and whether it's safe for long-term use.
Many people find it very difficult to lose weight through diet and exercise alone, and they need additional medical help. This trial is designed to see whether this medication could offer that extra support for weight management in people without diabetes.
You likely qualify if…
You likely don't qualify if…
If you qualify and are enrolled, you'll be randomly assigned to receive either the medication at one of three different doses or a placebo (a dummy injection with no active medicine). You'll receive weekly injections for up to 52 weeks, along with support for diet and exercise changes. You'll visit the clinic regularly so doctors can monitor your weight, health, and any side effects you experience.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China